Status:

UNKNOWN

Feeding Schedules After Surgery in Patients With Gynecologic Cancer

Lead Sponsor:

European Institute of Oncology

Conditions:

Female Reproductive Cancer

Eligibility:

FEMALE

Up to 75 years

Phase:

NA

Brief Summary

RATIONALE: Abdominal pain and nausea and vomiting may be lessened by waiting after surgery before eating foods by mouth. It is not yet known which feeding schedule is more effective in patients underg...

Detailed Description

OBJECTIVES: Primary * To investigate the relationship between the different policies of realimentation (early oral feedings versus traditional feedings) and the length of hospital stay following a l...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Preoperative diagnosis for probable gynecologic pathology
  • No benign pathology or final histopathology diagnosis confirmed as non-gynecologic disease
  • Admitted to the European Institute of Oncology
  • Elected to undergo laparotomic surgery
  • No total or anterior pelvic exenteration
  • No emergency laparotomy
  • PATIENT CHARACTERISTICS:
  • No metabolic pathology (e.g., diabetes mellitus type I)
  • No preoperative ASA score ≥ 4
  • No preoperative infection
  • No severe malnutrition (weight loss \> 10% within the past 3 months)
  • No preoperative intestinal obstruction
  • No postoperative admission to the intensive care unit (ICU) for more than 24 hours
  • No severe concomitant medical condition
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No prior abdominal and/or pelvis radiotherapy

Exclusion

    Key Trial Info

    Start Date :

    January 1 2007

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    180 Patients enrolled

    Trial Details

    Trial ID

    NCT00742677

    Start Date

    January 1 2007

    Last Update

    September 20 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    European Institute of Oncology

    Milan, Italy, 20141